| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.742 | 0.005 | 0.742 | Anticonvulsant | 0.42 0.019 CID_68498 0.496 0.012 CID_93911 | ||
| 0.655 | 0.004 | 0.655 | Dopamine antagonist | 0.115 0.033 CID_68498 0.112 0.034 CID_93911 | ||
| 0.653 | 0.004 | 0.653 | Dopamine D2 antagonist | 0.113 0.029 CID_68498 0.102 0.032 CID_93911 | ||
| 0.631 | 0.004 | 0.631 | 5 Hydroxytryptamine 2B antagonist | 0.222 0.023 CID_68498 0.188 0.029 CID_93911 | ||
| 0.598 | 0.002 | 0.598 | Sigma 2 receptor antagonist | 0.031 0.016 CID_68498 0.062 0.008 CID_93911 | ||
| 0.594 | 0.003 | 0.594 | Dopamine D1 antagonist | 0.121 0.02 CID_68498 0.246 0.008 CID_93911 | ||
| 0.557 | 0.005 | 0.557 | 5 Hydroxytryptamine 2 antagonist | 0.195 0.032 CID_68498 0.143 0.047 CID_93911 | ||
| 0.57 | 0.032 | 0.65 | Analgesic | 0.222 0.212 CID_68498 0.65 0.019 CID_93911 | CID_93911 | |
| 0.537 | 0.004 | 0.537 | 5 Hydroxytryptamine 2C antagonist | 0.135 0.031 CID_68498 0.17 0.022 CID_93911 | ||
| 0.481 | 0.005 | 0.481 | 5 Hydroxytryptamine 2A antagonist | 0.141 0.031 CID_68498 0.105 0.044 CID_93911 | ||
| 0.441 | 0.004 | 0.441 | Nav1.1 sodium channel blocker | 0.253 0.012 CID_68498 0.418 0.004 CID_93911 | ||
| 0.421 | 0.005 | 0.421 | Dopamine D4 antagonist | 0.083 0.031 CID_68498 0.053 0.046 CID_93911 | ||
| 0.413 | 0.005 | 0.537 | CC chemokine receptor antagonist | 0.537 0.004 CID_93911 | CID_93911 | |
| 0.407 | 0.004 | 0.407 | Dopamine D3 antagonist | 0.083 0.031 CID_68498 0.095 0.026 CID_93911 | ||
| 0.403 | 0.005 | 0.552 | Chemokine receptor antagonist | 0.552 0.004 CID_93911 | CID_93911 | |
| 0.398 | 0.005 | 0.398 | 5 Hydroxytryptamine 7 antagonist | 0.21 0.011 CID_93911 | ||
| 0.387 | 0.005 | 0.427 | NMDA receptor antagonist | 0.427 0.004 CID_93911 | CID_93911 | |
| 0.387 | 0.012 | 0.387 | 5 Hydroxytryptamine antagonist | 0.123 0.063 CID_68498 0.12 0.065 CID_93911 | ||
| 0.378 | 0.005 | 0.378 | Sigma receptor antagonist | 0.092 0.018 CID_68498 0.074 0.022 CID_93911 | ||
| 0.392 | 0.029 | 0.442 | HERG channel blocker | 0.442 0.021 CID_93911 | CID_93911 | |
| 0.371 | 0.032 | 0.407 | Potassium channel (Voltage-sensitive) blocker | 0.407 0.026 CID_93911 | CID_93911 | |
| 0.334 | 0.004 | 0.334 | Dopamine uptake inhibitor | 0.112 0.016 CID_68498 0.189 0.007 CID_93911 | ||
| 0.337 | 0.008 | 0.337 | 5 Hydroxytryptamine 1A antagonist | 0.078 0.041 CID_68498 0.081 0.04 CID_93911 | ||
| 0.352 | 0.032 | 0.352 | Potassium channel blocker | 0.258 0.063 CID_68498 0.207 0.088 CID_93911 | ||
| 0.324 | 0.009 | 0.324 | 5 Hydroxytryptamine 1 antagonist | 0.078 0.048 CID_68498 0.08 0.047 CID_93911 | ||
| 0.31 | 0.008 | 0.31 | Nav1.3 sodium channel blocker | 0.237 0.016 CID_68498 0.155 0.045 CID_93911 | ||
| 0.309 | 0.007 | 0.309 | Alpha 1b adrenoreceptor antagonist | 0.082 0.045 CID_68498 0.072 0.051 CID_93911 | ||
| 0.352 | 0.052 | 0.352 | Spasmolytic | 0.339 0.056 CID_68498 0.246 0.093 CID_93911 | ||
| 0.323 | 0.025 | 0.323 | P-glycoprotein inhibitor | 0.248 0.042 CID_68498 0.181 0.079 CID_93911 | ||
| 0.306 | 0.013 | 0.318 | Adenylate cyclase inhibitor | 0.162 0.038 CID_68498 0.318 0.012 CID_93911 | CID_93911 | |
| 0.296 | 0.003 | 0.296 | CC chemokine 1 receptor antagonist | 0.082 0.005 CID_93911 | ||
| 0.293 | 0.003 | 0.293 | Sphingosine 1-phosphate receptor 2 antagonist | 0.265 0.004 CID_68498 0.215 0.005 CID_93911 | ||
| 0.293 | 0.007 | 0.293 | Histamine H1 receptor antagonist | 0.139 0.027 CID_68498 | ||
| 0.28 | 0.007 | 0.305 | Nav1.6 sodium channel blocker | 0.305 0.005 CID_68498 0.161 0.043 CID_93911 | CID_68498 | |
| 0.286 | 0.017 | 0.286 | Nav1.2 sodium channel blocker | 0.27 0.019 CID_68498 0.146 0.059 CID_93911 | ||
| 0.333 | 0.065 | 0.363 | Apoptosis antagonist | 0.233 0.144 CID_68498 0.363 0.05 CID_93911 | CID_93911 | |
| 0.259 | 0.004 | 0.259 | Sphingosine 1-phosphate receptor 5 antagonist | 0.229 0.005 CID_68498 0.236 0.004 CID_93911 | ||
| 0.272 | 0.019 | 0.272 | Antipruritic | 0.191 0.056 CID_68498 0.24 0.028 CID_93911 | ||
| 0.245 | 0.015 | 0.245 | Alpha 2b adrenoreceptor antagonist | 0.142 0.043 CID_68498 0.189 0.026 CID_93911 | ||
| 0.236 | 0.007 | 0.315 | NMDA 2 receptor antagonist | 0.315 0.005 CID_93911 | CID_93911 | |
| 0.247 | 0.02 | 0.247 | Alpha adrenoreceptor antagonist | 0.082 0.07 CID_93911 | ||
| 0.297 | 0.073 | 0.348 | Lipoxygenase inhibitor | 0.348 0.051 CID_68498 0.243 0.105 CID_93911 | CID_68498 | |
| 0.216 | 0.005 | 0.261 | NMDA 2B receptor antagonist | 0.261 0.005 CID_93911 | CID_93911 | |
| 0.207 | 0.009 | 0.207 | Alpha 1d adrenoreceptor antagonist | 0.057 0.043 CID_68498 | ||
| 0.214 | 0.019 | 0.214 | Alpha 1 adrenoreceptor antagonist | |||
| 0.203 | 0.016 | 0.203 | Alpha 1a adrenoreceptor antagonist | |||
| 0.199 | 0.018 | 0.199 | Alpha 2c adrenoreceptor antagonist | 0.112 0.055 CID_68498 0.143 0.036 CID_93911 | ||
| 0.262 | 0.083 | 0.266 | Ca(v)3.3 blocker | 0.266 0.078 CID_68498 | CID_68498 | |
| 0.183 | 0.005 | 0.183 | Dopamine D5 antagonist | 0.061 0.019 CID_68498 0.057 0.021 CID_93911 | ||
| 0.177 | 0.005 | 0.177 | 5 Hydroxytryptamine 5A antagonist | 0.097 0.016 CID_68498 0.074 0.028 CID_93911 | ||
| 0.18 | 0.012 | 0.18 | 5 Hydroxytryptamine 1F antagonist | 0.129 0.021 CID_68498 0.147 0.017 CID_93911 | ||
| 0.165 | 0.005 | 0.165 | CC chemokine 3 receptor antagonist | 0.042 0.029 CID_93911 | ||
| 0.168 | 0.008 | 0.168 | Dopamine D4 agonist | |||
| 0.19 | 0.034 | 0.19 | Calcium channel blocker | 0.155 0.054 CID_68498 | ||
| 0.161 | 0.007 | 0.161 | 5 Hydroxytryptamine 5 antagonist | 0.088 0.018 CID_68498 0.064 0.031 CID_93911 | ||
| 0.154 | 0.005 | 0.154 | Sigma 1 receptor antagonist | 0.029 0.017 CID_68498 | ||
| 0.168 | 0.019 | 0.211 | Alpha 2a adrenoreceptor antagonist | 0.211 0.013 CID_93911 | CID_93911 | |
| 0.185 | 0.036 | 0.202 | Anesthetic local | 0.202 0.032 CID_68498 0.113 0.072 CID_93911 | CID_68498 | |
| 0.157 | 0.015 | 0.176 | Alpha adrenoreceptor agonist | 0.059 0.056 CID_68498 0.176 0.012 CID_93911 | CID_93911 | |
| 0.151 | 0.009 | 0.151 | Alpha 1 adrenoreceptor agonist | 0.059 0.037 CID_68498 0.06 0.036 CID_93911 | ||
| 0.154 | 0.015 | 0.215 | 5 Hydroxytryptamine uptake inhibitor | 0.215 0.01 CID_93911 | CID_93911 | |
| 0.256 | 0.121 | 0.445 | Cholesterol antagonist | 0.445 0.041 CID_68498 0.339 0.069 CID_93911 | CID_68498 | |
| 0.139 | 0.013 | 0.139 | Histamine H2 receptor antagonist | 0.114 0.024 CID_68498 0.093 0.042 CID_93911 | ||
| 0.155 | 0.03 | 0.155 | Antihistaminic | 0.091 0.063 CID_68498 | ||
| 0.155 | 0.031 | 0.155 | Calcium channel (voltage-sensitive) blocker | 0.115 0.064 CID_68498 | ||
| 0.206 | 0.083 | 0.214 | ErbB-1 antagonist | 0.214 0.076 CID_93911 | CID_93911 | |
| 0.147 | 0.03 | 0.147 | Histamine antagonist | 0.081 0.063 CID_68498 | ||
| 0.131 | 0.014 | 0.131 | Calcium channel L-type blocker | 0.108 0.021 CID_68498 0.067 0.057 CID_93911 | ||
| 0.151 | 0.035 | 0.151 | Antiadrenergic | |||
| 0.128 | 0.016 | 0.128 | Estrogen receptor alpha antagonist | 0.094 0.032 CID_68498 0.09 0.035 CID_93911 | ||
| 0.116 | 0.008 | 0.119 | Phospholipase D inhibitor | 0.118 0.007 CID_68498 0.119 0.007 CID_93911 | CID_93911 | |
| 0.118 | 0.011 | 0.118 | Calcium channel T-type blocker | 0.064 0.033 CID_93911 | ||
| 0.112 | 0.005 | 0.12 | Nicotinic alpha3beta2 receptor antagonist | 0.12 0.005 CID_68498 0.12 0.005 CID_93911 | CID_93911 | |
| 0.142 | 0.037 | 0.142 | Adrenaline antagonist | |||
| 0.154 | 0.049 | 0.228 | Glutamate receptor antagonist | 0.228 0.019 CID_93911 | CID_93911 | |
| 0.108 | 0.003 | 0.108 | GABA uptake inhibitor | 0.042 0.024 CID_68498 0.102 0.004 CID_93911 | ||
| 0.107 | 0.007 | 0.107 | CC chemokine 5 receptor antagonist | 0.103 0.007 CID_93911 | ||
| 0.163 | 0.063 | 0.163 | Acetylcholine M1 receptor antagonist | 0.152 0.073 CID_68498 0.162 0.064 CID_93911 | ||
| 0.252 | 0.155 | 0.406 | Antiobesity | 0.21 0.197 CID_68498 0.406 0.063 CID_93911 | CID_93911 | |
| 0.102 | 0.006 | 0.119 | MDM2 inhibitor | 0.071 0.035 CID_68498 0.119 0.004 CID_93911 | CID_93911 | |
| 0.137 | 0.043 | 0.192 | 5-Lipoxygenase inhibitor | 0.192 0.026 CID_68498 0.124 0.048 CID_93911 | CID_68498 | |
| 0.114 | 0.02 | 0.135 | Interferon agonist | 0.135 0.013 CID_68498 0.099 0.03 CID_93911 | CID_68498 | |
| 0.185 | 0.093 | 0.343 | Neurotrophic factor enhancer | 0.343 0.01 CID_68498 | CID_68498 | |
| 0.11 | 0.019 | 0.162 | Amidase inhibitor | 0.162 0.008 CID_68498 | CID_68498 | |
| 0.145 | 0.059 | 0.148 | Farnesoid X receptor antagonist | 0.138 0.068 CID_68498 0.148 0.054 CID_93911 | CID_93911 | |
| 0.102 | 0.018 | 0.226 | Adrenaline uptake inhibitor | 0.226 0.005 CID_93911 | CID_93911 | |
| 0.109 | 0.029 | 0.162 | Opioid kappa receptor antagonist | 0.162 0.015 CID_93911 | CID_93911 | |
| 0.105 | 0.025 | 0.105 | Dopamine agonist | |||
| 0.086 | 0.006 | 0.1 | Adenylate cyclase 1 inhibitor | 0.07 0.012 CID_68498 0.1 0.004 CID_93911 | CID_93911 | |
| 0.099 | 0.02 | 0.135 | Acetylcholine M5 receptor agonist | 0.135 0.007 CID_68498 0.066 0.048 CID_93911 | CID_68498 | |
| 0.102 | 0.025 | 0.113 | Leukotriene synthesis inhibitor | 0.095 0.029 CID_68498 0.113 0.019 CID_93911 | CID_93911 | |
| 0.142 | 0.066 | 0.142 | Neurotrophic factor | 0.139 0.07 CID_68498 0.114 0.105 CID_93911 | ||
| 0.14 | 0.065 | 0.178 | MAO inhibitor | 0.178 0.049 CID_68498 | CID_68498 | |
| 0.142 | 0.068 | 0.221 | Amylase inhibitor | 0.221 0.037 CID_68498 0.202 0.043 CID_93911 | CID_68498 | |
| 0.164 | 0.091 | 0.166 | DNA methyltransferase I inhibitor | 0.144 0.11 CID_68498 0.166 0.089 CID_93911 | CID_93911 | |
| 0.113 | 0.039 | 0.146 | Alpha 2 adrenoreceptor antagonist | 0.146 0.028 CID_93911 | CID_93911 | |
| 0.102 | 0.03 | 0.125 | Nicotinic alpha4beta2 receptor antagonist | 0.123 0.016 CID_68498 0.125 0.015 CID_93911 | CID_93911 | |
| 0.112 | 0.04 | 0.174 | Opioid antagonist | 0.174 0.019 CID_93911 | CID_93911 | |
| 0.088 | 0.017 | 0.221 | NMDA 2A receptor antagonist | 0.221 0.004 CID_93911 | CID_93911 | |
| 0.077 | 0.008 | 0.164 | Nociceptin (N/OFQ) receptor antagonist | 0.164 0.004 CID_93911 | CID_93911 | |
| 0.157 | 0.09 | 0.32 | Dual specificity phosphatase 3 inhibitor | 0.32 0.025 CID_68498 | CID_68498 | |
| 0.08 | 0.014 | 0.143 | Neurokinin 2 antagonist | 0.143 0.005 CID_93911 | CID_93911 | |
| 0.097 | 0.033 | 0.187 | Analgesic, opioid | 0.187 0.01 CID_93911 | CID_93911 | |
| 0.067 | 0.004 | 0.067 | Ceramide glucosyltransferase inhibitor | 0.061 0.004 CID_68498 0.039 0.019 CID_93911 | ||
| 0.194 | 0.131 | 0.249 | Neuropeptide Y2 antagonist | 0.249 0.057 CID_68498 0.219 0.09 CID_93911 | CID_68498 | |
| 0.155 | 0.094 | 0.218 | Tumour necrosis factor antagonist | 0.218 0.043 CID_68498 0.166 0.081 CID_93911 | CID_68498 | |
| 0.091 | 0.029 | 0.13 | Sphingosine 1-phosphate receptor antagonist | 0.13 0.01 CID_68498 0.082 0.042 CID_93911 | CID_68498 | |
| 0.084 | 0.025 | 0.323 | CDC25B inhibitor | 0.323 0.004 CID_68498 | CID_68498 | |
| 0.065 | 0.007 | 0.066 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.035 0.019 CID_68498 0.066 0.007 CID_93911 | CID_93911 | |
| 0.117 | 0.06 | 0.117 | Estrogen antagonist | 0.1 0.098 CID_68498 0.106 0.084 CID_93911 | ||
| 0.074 | 0.022 | 0.074 | Cannabinoid CB2 receptor antagonist | 0.051 0.036 CID_68498 0.048 0.038 CID_93911 | ||
| 0.161 | 0.108 | 0.164 | DNA methylase inhibitor | 0.135 0.132 CID_68498 0.164 0.106 CID_93911 | CID_93911 | |
| 0.117 | 0.065 | 0.15 | Interleukin 1b antagonist | 0.15 0.04 CID_68498 0.099 0.082 CID_93911 | CID_68498 | |
| 0.137 | 0.086 | 0.179 | Ca2+-transporting ATPase inhibitor | 0.179 0.007 CID_68498 0.156 0.03 CID_93911 | CID_68498 | |
| 0.071 | 0.022 | 0.071 | 5 Hydroxytryptamine 1A agonist | |||
| 0.057 | 0.008 | 0.057 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.031 CID_68498 0.043 0.018 CID_93911 | ||
| 0.086 | 0.037 | 0.143 | Opioid mu receptor antagonist | 0.143 0.019 CID_93911 | CID_93911 | |
| 0.111 | 0.064 | 0.133 | 5 Hydroxytryptamine 3A agonist | 0.13 0.048 CID_68498 0.133 0.046 CID_93911 | CID_93911 | |
| 0.08 | 0.034 | 0.132 | Potassium channel (Tandem pore domain) blocker | 0.132 0.004 CID_68498 | CID_68498 | |
| 0.169 | 0.123 | 0.279 | Cyclic AMP phosphodiesterase inhibitor | 0.22 0.08 CID_68498 0.279 0.051 CID_93911 | CID_93911 | |
| 0.058 | 0.012 | 0.164 | Substance P antagonist | 0.164 0.004 CID_93911 | CID_93911 | |
| 0.083 | 0.038 | 0.09 | Cannabinoid receptor antagonist | 0.09 0.033 CID_93911 | CID_93911 | |
| 0.085 | 0.04 | 0.085 | Viral attachment inhibitor | 0.085 0.04 CID_93911 | ||
| 0.054 | 0.009 | 0.054 | Heme oxygenase inhibitor | 0.048 0.016 CID_68498 0.041 0.036 CID_93911 | ||
| 0.199 | 0.154 | 0.595 | 5 Hydroxytryptamine uptake stimulant | 0.595 0.003 CID_68498 0.342 0.028 CID_93911 | CID_68498 | |
| 0.077 | 0.033 | 0.077 | 5 Hydroxytryptamine 1D antagonist | 0.077 0.033 CID_93911 | ||
| 0.062 | 0.019 | 0.085 | Potassium channel Kv1.3 blocker | 0.085 0.011 CID_68498 0.042 0.04 CID_93911 | CID_68498 | |
| 0.067 | 0.025 | 0.067 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.084 | 0.042 | 0.147 | GABA aminotransferase inhibitor | 0.147 0.008 CID_68498 0.09 0.035 CID_93911 | CID_68498 | |
| 0.114 | 0.073 | 0.114 | Acetylcholine muscarinic antagonist | 0.111 0.078 CID_68498 | ||
| 0.119 | 0.079 | 0.119 | Acetylcholinesterase inhibitor | 0.118 0.08 CID_68498 | ||
| 0.064 | 0.025 | 0.073 | 5 Hydroxytryptamine 7 agonist | 0.073 0.017 CID_68498 0.055 0.04 CID_93911 | CID_68498 | |
| 0.071 | 0.032 | 0.217 | NMDA 2C receptor antagonist | 0.217 0.005 CID_93911 | CID_93911 | |
| 0.116 | 0.078 | 0.117 | Cholinergic antagonist | 0.103 0.092 CID_68498 0.117 0.077 CID_93911 | CID_93911 | |
| 0.141 | 0.104 | 0.293 | Dual specificity phosphatase inhibitor | 0.293 0.03 CID_68498 | CID_68498 | |
| 0.113 | 0.077 | 0.115 | Acetylcholine antagonist | 0.1 0.093 CID_68498 0.115 0.075 CID_93911 | CID_93911 | |
| 0.268 | 0.232 | 0.482 | Caspase 9 stimulant | 0.482 0.067 CID_68498 0.413 0.103 CID_93911 | CID_68498 | |
| 0.096 | 0.062 | 0.148 | Lanosterol 14 alpha demethylase inhibitor | 0.148 0.012 CID_68498 0.114 0.037 CID_93911 | CID_68498 | |
| 0.054 | 0.022 | 0.059 | Nicotinic receptor alpha3 subunit antagonist | 0.055 0.021 CID_68498 0.059 0.02 CID_93911 | CID_93911 | |
| 0.05 | 0.018 | 0.062 | Nerve growth factor antagonist | 0.062 0.008 CID_93911 | CID_93911 | |
| 0.191 | 0.163 | 0.233 | Hypoxia-inducible factor 1 alpha inhibitor | 0.231 0.118 CID_68498 0.233 0.116 CID_93911 | CID_93911 | |
| 0.107 | 0.081 | 0.191 | Interleukin 8 antagonist | 0.131 0.049 CID_68498 0.191 0.015 CID_93911 | CID_93911 | |
| 0.063 | 0.038 | 0.065 | Acetylcholine M5 receptor antagonist | 0.065 0.036 CID_68498 0.054 0.052 CID_93911 | CID_68498 | |
| 0.117 | 0.093 | 0.205 | Interleukin 1 antagonist | 0.205 0.03 CID_68498 | CID_68498 | |
| 0.033 | 0.01 | 0.033 | DNA polymerase III inhibitor | 0.033 0.01 CID_93911 | ||
| 0.044 | 0.023 | 0.264 | NMDA receptor subunit 3A antagonist | 0.264 0.004 CID_93911 | CID_93911 | |
| 0.055 | 0.034 | 0.088 | Nicotinic receptor alpha7 subunit antagonist | 0.059 0.03 CID_68498 0.088 0.015 CID_93911 | CID_93911 | |
| 0.031 | 0.01 | 0.045 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.045 0.004 CID_93911 | CID_93911 | |
| 0.09 | 0.07 | 0.12 | Alpha 2d adrenoreceptor antagonist | 0.12 0.024 CID_68498 | CID_68498 | |
| 0.073 | 0.053 | 0.087 | Acetylcholine M4 receptor antagonist | 0.087 0.039 CID_68498 0.08 0.047 CID_93911 | CID_68498 | |
| 0.054 | 0.035 | 0.086 | Alpha-mannosidase inhibitor | 0.064 0.022 CID_68498 0.086 0.009 CID_93911 | CID_93911 | |
| 0.069 | 0.05 | 0.147 | HIV-1 integrase inhibitor | 0.147 0.009 CID_68498 | CID_68498 | |
| 0.123 | 0.104 | 0.123 | Cholinergic | |||
| 0.176 | 0.159 | 0.229 | 5 Hydroxytryptamine 1E antagonist | 0.229 0.098 CID_68498 0.229 0.098 CID_93911 | CID_93911 | |
| 0.049 | 0.033 | 0.084 | Dopamine transporter inhibitor | 0.084 0.015 CID_93911 | CID_93911 | |
| 0.061 | 0.044 | 0.077 | Cannabinoid CB1 receptor antagonist | 0.077 0.029 CID_93911 | CID_93911 | |
| 0.033 | 0.018 | 0.156 | Lysophosphatidic acid 2 receptor antagonist | 0.156 0.003 CID_68498 | CID_68498 | |
| 0.024 | 0.009 | 0.035 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.035 0.004 CID_93911 | CID_93911 | |
| 0.021 | 0.008 | 0.021 | CXC chemokine 5 receptor antagonist | 0.017 0.015 CID_68498 | ||
| 0.052 | 0.039 | 0.165 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.165 0.004 CID_68498 | CID_68498 | |
| 0.041 | 0.028 | 0.072 | Thymidine kinase inhibitor | 0.072 0.01 CID_93911 | CID_93911 | |
| 0.05 | 0.037 | 0.05 | 5 Hydroxytryptamine 1 agonist | |||
| 0.168 | 0.156 | 0.368 | RNA-directed DNA polymerase inhibitor | 0.219 0.075 CID_68498 0.368 0.022 CID_93911 | CID_93911 | |
| 0.057 | 0.045 | 0.057 | Acetylcholine M3 receptor antagonist | 0.056 0.046 CID_93911 | ||
| 0.035 | 0.024 | 0.117 | Glutamate (mGluR group II) agonist | 0.117 0.005 CID_68498 | CID_68498 | |
| 0.048 | 0.037 | 0.1 | Neurokinin antagonist | 0.1 0.011 CID_93911 | CID_93911 | |
| 0.083 | 0.073 | 0.142 | MAO B inhibitor | 0.142 0.04 CID_68498 | CID_68498 | |
| 0.091 | 0.082 | 0.091 | Estrogen receptor beta antagonist | |||
| 0.032 | 0.023 | 0.111 | Glutamate (mGluR2) agonist | 0.111 0.005 CID_68498 | CID_68498 | |
| 0.077 | 0.069 | 0.127 | Androgen antagonist | 0.112 0.038 CID_68498 0.127 0.03 CID_93911 | CID_93911 | |
| 0.095 | 0.087 | 0.164 | DOPA decarboxylase inhibitor | 0.164 0.015 CID_68498 0.114 0.053 CID_93911 | CID_68498 | |
| 0.014 | 0.007 | 0.014 | DNA polymerase III polC-type inhibitor | 0.014 0.008 CID_93911 | ||
| 0.072 | 0.066 | 0.119 | Acetylcholine nicotinic antagonist | 0.087 0.048 CID_68498 0.119 0.03 CID_93911 | CID_93911 | |
| 0.046 | 0.04 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 CID_68498 0.048 0.036 CID_93911 | CID_68498 | |
| 0.049 | 0.046 | 0.062 | CC chemokine 2 receptor antagonist | 0.062 0.031 CID_93911 | CID_93911 | |
| 0.066 | 0.064 | 0.207 | CDC25A inhibitor | 0.207 0.006 CID_68498 | CID_68498 | |
| 0.1 | 0.099 | 0.169 | Cyclooxygenase 1 inhibitor | 0.169 0.048 CID_68498 | CID_68498 | |
| 0.041 | 0.04 | 0.045 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.045 0.035 CID_93911 | CID_93911 | |
| 0.149 | 0.149 | 0.248 | Antiamyloidogenic | 0.248 0.072 CID_68498 | CID_68498 | |
| 0.036 | 0.037 | 0.079 | Neurokinin 1 antagonist | 0.079 0.01 CID_93911 | CID_93911 | |
| 0.022 | 0.024 | 0.073 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 CID_68498 | CID_68498 | |
| 0.094 | 0.096 | 0.186 | Cholesterol synthesis inhibitor | 0.186 0.03 CID_68498 | CID_68498 | |
| 0.123 | 0.127 | 0.211 | Interferon gamma antagonist | 0.211 0.037 CID_68498 0.146 0.083 CID_93911 | CID_68498 | |
| 0.075 | 0.079 | 0.088 | Thioredoxin reductase inhibitor | 0.088 0.045 CID_68498 | CID_68498 | |
| 0.016 | 0.021 | 0.049 | Nociceptin (N/OFQ) receptor agonist | 0.049 0.005 CID_93911 | CID_93911 | |
| 0.045 | 0.05 | 0.058 | 5 Hydroxytryptamine 4 antagonist | 0.058 0.026 CID_68498 | CID_68498 | |
| 0.018 | 0.024 | 0.036 | Prostaglandin E2 agonist | 0.036 0.008 CID_68498 | CID_68498 | |
| 0.072 | 0.077 | 0.079 | Histamine N-methyltransferase inhibitor | 0.079 0.068 CID_93911 | CID_93911 | |
| 0.033 | 0.039 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | 0.053 0.023 CID_68498 | CID_68498 | |
| 0.038 | 0.044 | 0.088 | Mannosidase inhibitor | 0.048 0.028 CID_68498 0.088 0.007 CID_93911 | CID_93911 | |
| 0.025 | 0.032 | 0.039 | Estrogen-related receptor gamma antagonist | 0.032 0.012 CID_68498 0.039 0.006 CID_93911 | CID_93911 | |
| 0.051 | 0.06 | 0.067 | Leukotriene C antagonist | 0.067 0.017 CID_68498 | CID_68498 | |
| 0.024 | 0.033 | 0.053 | Prostaglandin agonist | 0.053 0.009 CID_68498 | CID_68498 | |
| 0.027 | 0.036 | 0.052 | Catechol O-methyltransferase inhibitor | 0.052 0.008 CID_68498 | CID_68498 | |
| 0.049 | 0.059 | 0.166 | Sphingosine 1-phosphate receptor 3 antagonist | 0.166 0.004 CID_68498 | CID_68498 | |
| 0.053 | 0.064 | 0.094 | Neuronal nicotinic receptor antagonist | 0.072 0.044 CID_68498 0.094 0.027 CID_93911 | CID_93911 | |
| 0.04 | 0.053 | 0.1 | Opioid agonist | 0.1 0.013 CID_93911 | CID_93911 | |
| 0.175 | 0.188 | 0.329 | Tyrosine 3 hydroxylase inhibitor | 0.307 0.03 CID_68498 0.329 0.022 CID_93911 | CID_93911 | |
| 0.03 | 0.044 | 0.037 | Histamine H3 receptor antagonist | 0.037 0.036 CID_68498 | CID_68498 | |
| 0.147 | 0.162 | 0.228 | Vasodilator | 0.228 0.083 CID_68498 | CID_68498 | |
| 0.047 | 0.063 | 0.097 | 5 Hydroxytryptamine 2A agonist | 0.097 0.016 CID_68498 0.091 0.019 CID_93911 | CID_68498 | |
| 0.035 | 0.051 | 0.075 | Opioid mu receptor agonist | 0.075 0.019 CID_93911 | CID_93911 | |
| 0.012 | 0.031 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 CID_93911 | CID_93911 | |
| 0.13 | 0.151 | 0.34 | Non-steroidal antiinflammatory agent | 0.34 0.021 CID_68498 | CID_68498 | |
| 0.032 | 0.053 | 0.081 | Phenylethanolamine N methyltransferase inhibitor | 0.081 0.004 CID_93911 | CID_93911 | |
| 0.042 | 0.063 | 0.101 | Opioid delta receptor antagonist | 0.101 0.03 CID_93911 | CID_93911 | |
| 0.054 | 0.077 | 0.084 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 CID_68498 0.084 0.021 CID_93911 | CID_93911 | |
| 0.049 | 0.071 | 0.062 | Prostaglandin F2 alpha antagonist | 0.062 0.043 CID_93911 | CID_93911 | |
| 0.009 | 0.032 | 0.022 | Thyroid hormone alpha antagonist | 0.022 0.006 CID_68498 | CID_68498 | |
| 0.025 | 0.049 | 0.15 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.15 0.003 CID_68498 | CID_68498 | |
| 0.051 | 0.076 | 0.097 | Ryanodine receptor antagonist | 0.097 0.005 CID_93911 | CID_93911 | |
| 0.028 | 0.055 | 0.08 | Delayed rectifier potassium channel blocker | 0.08 0.004 CID_68498 | CID_68498 | |
| 0.029 | 0.058 | 0.2 | NMDA receptor subunit 3B antagonist | 0.2 0.004 CID_93911 | CID_93911 | |
| 0.131 | 0.16 | 0.158 | Catenin beta inhibitor | 0.158 0.089 CID_68498 0.142 0.127 CID_93911 | CID_68498 | |
| 0.045 | 0.075 | 0.065 | 5 Hydroxytryptamine agonist | 0.065 0.051 CID_93911 | CID_93911 | |
| 0.032 | 0.062 | 0.044 | Leukotriene C4 antagonist | 0.044 0.017 CID_68498 | CID_68498 | |
| 0.062 | 0.093 | 0.144 | Glycine receptor antagonist | 0.131 0.013 CID_68498 0.144 0.009 CID_93911 | CID_93911 | |
| 0.051 | 0.082 | 0.083 | Interferon inducer | 0.059 0.056 CID_68498 0.083 0.021 CID_93911 | CID_93911 | |
| 0.027 | 0.058 | 0.051 | Acetylcholine M1 receptor agonist | 0.042 0.031 CID_68498 0.051 0.025 CID_93911 | CID_93911 | |
| 0.068 | 0.099 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | 0.192 0.013 CID_68498 0.142 0.029 CID_93911 | CID_68498 | |
| 0.072 | 0.103 | 0.204 | Creatine kinase inhibitor | 0.204 0.01 CID_68498 0.087 0.076 CID_93911 | CID_68498 | |
| 0.072 | 0.105 | 0.121 | Thioredoxin inhibitor | 0.121 0.03 CID_68498 | CID_68498 | |
| 0.053 | 0.086 | 0.195 | Glutamate receptor agonist | 0.195 0.011 CID_68498 | CID_68498 | |
| 0.014 | 0.049 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_93911 | CID_93911 | |
| 0.071 | 0.107 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.05 CID_68498 | CID_68498 | |
| 0.034 | 0.071 | 0.098 | Potassium channel (Inward rectifier) blocker | 0.098 0.007 CID_68498 | CID_68498 | |
| 0.113 | 0.153 | 0.155 | Pregnane X receptor agonist | 0.138 0.078 CID_68498 0.155 0.044 CID_93911 | CID_93911 | |
| 0.006 | 0.046 | 0.065 | Calcium-dependent phospholipase A2 inhibitor | 0.065 0.003 CID_68498 | CID_68498 | |
| 0.04 | 0.08 | 0.069 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.069 0.031 CID_68498 | CID_68498 | |
| 0.004 | 0.044 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 CID_68498 | CID_68498 | |
| 0.023 | 0.064 | 0.04 | Estrogen-related receptor beta antagonist | 0.04 0.011 CID_93911 | CID_93911 | |
| 0.017 | 0.059 | 0.064 | Progesterone antagonist | 0.064 0.014 CID_68498 | CID_68498 | |
| 0.009 | 0.054 | 0.051 | Prostaglandin EP2 agonist | 0.051 0.005 CID_68498 | CID_68498 | |
| 0.033 | 0.077 | 0.075 | Cholesterol esterase inhibitor | 0.075 0.008 CID_68498 | CID_68498 | |
| 0.115 | 0.16 | 0.155 | Interleukin 6 antagonist | 0.155 0.082 CID_68498 | CID_68498 | |
| 0.111 | 0.157 | 0.201 | Platelet adhesion inhibitor | 0.201 0.071 CID_93911 | CID_93911 | |
| 0.033 | 0.081 | 0.061 | Cannabinoid CB1 receptor agonist | 0.061 0.042 CID_68498 | CID_68498 | |
| 0.068 | 0.117 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 CID_68498 0.09 0.044 CID_93911 | CID_68498 | |
| 0.075 | 0.125 | 0.109 | Beta glucuronidase inhibitor | 0.095 0.077 CID_68498 0.109 0.058 CID_93911 | CID_93911 | |
| 0.034 | 0.084 | 0.098 | HIV-1 integrase (Strand Transfer) inhibitor | 0.098 0.023 CID_68498 | CID_68498 | |
| 0.091 | 0.141 | 0.142 | Transcription factor STAT6 inhibitor | 0.142 0.03 CID_68498 | CID_68498 | |
| 0.035 | 0.085 | 0.084 | 5 Hydroxytryptamine 6 antagonist | 0.084 0.021 CID_93911 | CID_93911 | |
| 0.11 | 0.161 | 0.182 | Pyruvate kinase inhibitor | 0.182 0.092 CID_68498 0.152 0.113 CID_93911 | CID_68498 | |
| 0.016 | 0.069 | 0.037 | Peptide deformylase inhibitor | 0.037 0.016 CID_68498 | CID_68498 | |
| 0.037 | 0.09 | 0.048 | CD45 antagonist | 0.048 0.04 CID_68498 | CID_68498 | |
| 0.07 | 0.123 | 0.15 | Nitric-oxide synthase inhibitor | 0.11 0.046 CID_68498 0.15 0.022 CID_93911 | CID_93911 | |
| 0.018 | 0.074 | 0.032 | MAP3K8 inhibitor | 0.032 0.015 CID_93911 | CID_93911 | |
| 0.184 | 0.24 | 0.321 | Calcium channel activator | 0.272 0.122 CID_68498 0.321 0.072 CID_93911 | CID_93911 | |
| 0.031 | 0.089 | 0.196 | H+/K+-transporting ATPase inhibitor | 0.196 0.004 CID_68498 | CID_68498 | |
| 0.075 | 0.133 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.054 CID_68498 | CID_68498 | |
| 0.022 | 0.081 | 0.089 | Glycine transporter 2 inhibitor | 0.089 0.015 CID_68498 | CID_68498 | |
| 0.044 | 0.106 | 0.117 | Glutamate decarboxylase inhibitor | 0.117 0.022 CID_68498 0.085 0.04 CID_93911 | CID_68498 | |
| 0.013 | 0.075 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.023 CID_68498 | CID_68498 | |
| 0.086 | 0.148 | 0.169 | Cyclooxygenase inhibitor | 0.169 0.057 CID_68498 | CID_68498 | |
| 0.105 | 0.167 | 0.131 | Nitric oxide antagonist | 0.131 0.118 CID_68498 | CID_68498 | |
| 0.078 | 0.141 | 0.14 | Cyclooxygenase 2 inhibitor | 0.14 0.062 CID_68498 | CID_68498 | |
| 0.038 | 0.103 | 0.06 | Sphingosine 1-phosphate receptor 5 agonist | 0.06 0.025 CID_68498 | CID_68498 | |
| 0.116 | 0.18 | 0.267 | Hypolipemic | 0.267 0.06 CID_68498 | CID_68498 | |
| 0.061 | 0.125 | 0.139 | Sphingomyelinase inhibitor | 0.139 0.03 CID_68498 0.083 0.082 CID_93911 | CID_68498 | |
| 0.032 | 0.097 | 0.142 | Glutamate (mGluR) agonist | 0.142 0.015 CID_68498 | CID_68498 | |
| 0.24 | 0.305 | 0.418 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.418 0.085 CID_68498 0.383 0.117 CID_93911 | CID_68498 | |
| 0.017 | 0.082 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.026 CID_68498 | CID_68498 | |
| 0.013 | 0.082 | 0.05 | Protease activated receptor 1 antagonist | 0.05 0.032 CID_68498 | CID_68498 | |
| 0.028 | 0.099 | 0.054 | Histamine H1 receptor agonist | 0.05 0.018 CID_68498 0.054 0.014 CID_93911 | CID_93911 | |
| 0.037 | 0.109 | 0.077 | Glucosylceramidase inhibitor | 0.05 0.048 CID_68498 0.077 0.017 CID_93911 | CID_93911 | |
| 0.019 | 0.092 | 0.034 | RNA-directed RNA polymerase inhibitor | 0.034 0.024 CID_68498 | CID_68498 | |
| 0.027 | 0.101 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 CID_68498 0.048 0.017 CID_93911 | CID_68498 | |
| 0.027 | 0.102 | 0.053 | Acetylcholine muscarinic agonist | 0.051 0.042 CID_68498 0.053 0.039 CID_93911 | CID_93911 | |
| 0.034 | 0.109 | 0.181 | Alpha 2 adrenoreceptor agonist | 0.181 0.005 CID_93911 | CID_93911 | |
| 0.112 | 0.189 | 0.235 | Lipocortins synthesis antagonist | 0.235 0.039 CID_68498 | CID_68498 | |
| 0.136 | 0.213 | 0.482 | Superoxide dismutase inhibitor | 0.482 0.015 CID_68498 0.182 0.14 CID_93911 | CID_68498 | |
| 0.101 | 0.179 | 0.352 | Anesthetic general | 0.352 0.024 CID_68498 0.143 0.122 CID_93911 | CID_68498 | |
| 0.005 | 0.084 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.009 CID_93911 | CID_93911 | |
| 0.155 | 0.234 | 0.474 | Vasodilator, peripheral | 0.474 0.034 CID_68498 | CID_68498 | |
| 0.054 | 0.135 | 0.11 | Vanilloid 4 agonist | 0.11 0.01 CID_68498 0.081 0.039 CID_93911 | CID_68498 | |
| 0.012 | 0.096 | 0.041 | Prostaglandin D2 agonist | 0.041 0.012 CID_68498 | CID_68498 | |
| 0.047 | 0.132 | 0.086 | MAO A inhibitor | 0.086 0.075 CID_68498 | CID_68498 | |
| 0.034 | 0.12 | 0.061 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 CID_68498 | CID_68498 | |
| 0.173 | 0.26 | 0.273 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.273 0.042 CID_93911 | CID_93911 | |
| 0.031 | 0.118 | 0.065 | Cytokine production stimulant | 0.065 0.009 CID_68498 | CID_68498 | |
| 0.139 | 0.228 | 0.29 | DNA synthesis inhibitor | 0.29 0.047 CID_68498 0.213 0.104 CID_93911 | CID_68498 | |
| 0.055 | 0.144 | 0.122 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 CID_68498 | CID_68498 | |
| 0.048 | 0.139 | 0.094 | Acetylcholine agonist | 0.094 0.052 CID_93911 | CID_93911 | |
| 0.016 | 0.108 | 0.03 | Thymidine phosphorylase inhibitor | 0.03 0.011 CID_93911 | CID_93911 | |
| 0.063 | 0.157 | 0.079 | Hematopoietic | 0.079 0.075 CID_68498 | CID_68498 | |
| 0.025 | 0.119 | 0.052 | Vanilloid 3 antagonist | 0.052 0.008 CID_68498 | CID_68498 | |
| 0.021 | 0.116 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.019 CID_93911 | CID_93911 | |
| 0.008 | 0.103 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 CID_68498 | CID_68498 | |
| 0.009 | 0.105 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 CID_93911 | CID_93911 | |
| 0.045 | 0.14 | 0.138 | Macrophage migration inhibitory factor inhibitor | 0.138 0.019 CID_68498 | CID_68498 | |
| 0.101 | 0.199 | 0.18 | Death-associated protein kinase 1 inhibitor | 0.18 0.013 CID_68498 | CID_68498 | |
| 0.022 | 0.121 | 0.08 | Thromboxane antagonist | 0.08 0.02 CID_68498 | CID_68498 | |
| 0.026 | 0.127 | 0.058 | GABA B receptor antagonist | 0.055 0.015 CID_68498 0.058 0.013 CID_93911 | CID_93911 | |
| 0.082 | 0.183 | 0.15 | Protein-tyrosine phosphatase inhibitor | 0.15 0.078 CID_68498 | CID_68498 | |
| 0.013 | 0.115 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 CID_93911 | CID_93911 | |
| 0.087 | 0.189 | 0.201 | Mannose-6-phosphate isomerase inhibitor | 0.201 0.03 CID_68498 | CID_68498 | |
| 0.007 | 0.109 | 0.03 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.03 0.012 CID_68498 | CID_68498 | |
| 0.012 | 0.115 | 0.018 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.015 CID_68498 | CID_68498 | |
| 0.018 | 0.121 | 0.076 | Thromboxane A2 antagonist | 0.076 0.017 CID_68498 | CID_68498 | |
| 0.135 | 0.239 | 0.274 | Thioredoxin glutathione reductase inhibitor | 0.274 0.119 CID_68498 | CID_68498 | |
| 0.013 | 0.117 | 0.054 | Carbonic anhydrase VII inhibitor | 0.054 0.024 CID_93911 | CID_93911 | |
| 0.015 | 0.12 | 0.035 | Thrombin receptor antagonist | 0.035 0.014 CID_68498 | CID_68498 | |
| 0.043 | 0.15 | 0.066 | Kallikrein 7 inhibitor | 0.066 0.037 CID_68498 | CID_68498 | |
| 0.014 | 0.121 | 0.076 | Purinergic P2Y antagonist | 0.076 0.014 CID_68498 | CID_68498 | |
| 0.016 | 0.124 | 0.072 | Factor XIIIa inhibitor | 0.072 0.009 CID_68498 | CID_68498 | |
| 0.081 | 0.19 | 0.205 | Psychostimulant | 0.201 0.079 CID_68498 0.205 0.077 CID_93911 | CID_93911 | |
| 0.054 | 0.165 | 0.256 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.256 0.009 CID_68498 | CID_68498 | |
| 0.016 | 0.128 | 0.094 | Dopamine D5 agonist | 0.041 0.027 CID_68498 0.094 0.005 CID_93911 | CID_93911 | |
| 0.037 | 0.149 | 0.09 | Aryl hydrocarbon receptor antagonist | 0.09 0.019 CID_68498 | CID_68498 | |
| 0.139 | 0.252 | 0.295 | Nitric-oxide synthase stimulant | 0.295 0.013 CID_68498 0.206 0.079 CID_93911 | CID_68498 | |
| 0.092 | 0.205 | 0.132 | Papain-like protease (SARS coronavirus) inhibitor | 0.132 0.057 CID_68498 | CID_68498 | |
| 0.063 | 0.178 | 0.15 | Caspase 3 inhibitor | 0.15 0.028 CID_68498 | CID_68498 | |
| 0.04 | 0.159 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 CID_68498 | CID_68498 | |
| 0.025 | 0.143 | 0.141 | Acetyl-CoA transferase inhibitor | 0.141 0.006 CID_68498 | CID_68498 | |
| 0.029 | 0.149 | 0.06 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.031 CID_68498 | CID_68498 | |
| 0.14 | 0.26 | 0.209 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.209 0.147 CID_93911 | CID_93911 | |
| 0.012 | 0.132 | 0.035 | HMG CoA reductase inhibitor | 0.035 0.023 CID_68498 | CID_68498 | |
| 0.123 | 0.245 | 0.35 | Thyroid hormone antagonist | 0.35 0.073 CID_68498 | CID_68498 | |
| 0.13 | 0.252 | 0.291 | Transcription factor NF kappa B inhibitor | 0.291 0.099 CID_68498 0.203 0.166 CID_93911 | CID_68498 | |
| 0.026 | 0.148 | 0.045 | Glutamate (mGluR group III) antagonist | 0.045 0.029 CID_68498 0.04 0.039 CID_93911 | CID_68498 | |
| 0.013 | 0.135 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.03 CID_68498 | CID_68498 | |
| 0.003 | 0.126 | 0.021 | Kainate receptor 1 antagonist | 0.021 0.015 CID_93911 | CID_93911 | |
| 0.066 | 0.189 | 0.106 | Calcium channel N-type blocker | 0.106 0.085 CID_68498 | CID_68498 | |
| 0.022 | 0.146 | 0.062 | Prolyl endopeptidase inhibitor | 0.062 0.023 CID_68498 | CID_68498 | |
| 0.028 | 0.154 | 0.048 | Squalene epoxidase inhibitor | 0.048 0.038 CID_68498 | CID_68498 | |
| 0.006 | 0.133 | 0.016 | Telomerase stimulant | 0.016 0.015 CID_93911 | CID_93911 | |
| 0.116 | 0.243 | 0.245 | Histone acetyltransferase inhibitor | 0.245 0.027 CID_68498 | CID_68498 | |
| 0.023 | 0.152 | 0.057 | Nicotinic receptor alpha4 subunit antagonist | 0.057 0.024 CID_93911 | CID_93911 | |
| 0.08 | 0.209 | 0.216 | Arachidonic acid antagonist | 0.216 0.02 CID_68498 0.162 0.075 CID_93911 | CID_68498 | |
| 0.009 | 0.138 | 0.047 | Kainate receptor 2 antagonist | 0.047 0.018 CID_93911 | CID_93911 | |
| 0.035 | 0.165 | 0.099 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.099 0.011 CID_68498 | CID_68498 | |
| 0.012 | 0.143 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.038 0.012 CID_93911 | CID_93911 | |
| 0.015 | 0.147 | 0.126 | Oleamide hydrolase inhibitor | 0.126 0.006 CID_68498 | CID_68498 | |
| 0.089 | 0.222 | 0.21 | Insulin sensitizer | 0.21 0.064 CID_68498 | CID_68498 | |
| 0.049 | 0.183 | 0.16 | UDP-glucose 4-epimerase inhibitor | 0.16 0.026 CID_68498 0.127 0.039 CID_93911 | CID_68498 | |
| 0.021 | 0.155 | 0.035 | Adenosine uptake inhibitor | 0.035 0.022 CID_68498 | CID_68498 | |
| 0.021 | 0.155 | 0.055 | Nicotinic neuronal receptor agonist | 0.055 0.04 CID_93911 | CID_93911 | |
| 0.015 | 0.15 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.01 CID_68498 | CID_68498 | |
| 0.01 | 0.145 | 0.025 | 5 Hydroxytryptamine 1F agonist | 0.025 0.018 CID_68498 | CID_68498 | |
| 0.049 | 0.185 | 0.094 | GABA B receptor agonist | 0.094 0.021 CID_68498 0.087 0.03 CID_93911 | CID_68498 | |
| 0.125 | 0.261 | 0.223 | Transcription factor STAT3 inhibitor | 0.223 0.108 CID_68498 | CID_68498 | |
| 0.135 | 0.272 | 0.232 | Transcription factor STAT inhibitor | 0.232 0.1 CID_68498 | CID_68498 | |
| 0.037 | 0.175 | 0.191 | Monophenol monooxygenase inhibitor | 0.191 0.035 CID_68498 | CID_68498 | |
| 0.041 | 0.184 | 0.098 | Urease inhibitor | 0.098 0.069 CID_68498 0.093 0.075 CID_93911 | CID_68498 | |
| 0.024 | 0.168 | 0.047 | Glutamate (mGluR4) antagonist | 0.047 0.024 CID_93911 | CID_93911 | |
| 0.061 | 0.205 | 0.122 | Glutamate (mGluR7) agonist | 0.122 0.028 CID_68498 | CID_68498 | |
| 0.031 | 0.177 | 0.089 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.089 0.044 CID_68498 | CID_68498 | |
| 0.023 | 0.169 | 0.082 | Leukotriene antagonist | 0.082 0.03 CID_68498 | CID_68498 | |
| 0.023 | 0.169 | 0.087 | Purinergic P2X4 antagonist | 0.087 0.005 CID_93911 | CID_93911 | |
| 0.032 | 0.179 | 0.15 | Potassium channel (ATP-sensitive) blocker | 0.15 0.005 CID_68498 | CID_68498 | |
| 0.081 | 0.228 | 0.125 | NOS3 expression enhancer | 0.125 0.105 CID_68498 | CID_68498 | |
| 0.025 | 0.172 | 0.065 | Potassium channel (ATP-sensitive) activator | 0.065 0.012 CID_68498 0.055 0.021 CID_93911 | CID_68498 | |
| 0.035 | 0.183 | 0.093 | Acetylcholine nicotinic agonist | 0.093 0.043 CID_93911 | CID_93911 | |
| 0.043 | 0.192 | 0.101 | Antineoplastic alkaloid | 0.101 0.047 CID_93911 | CID_93911 | |
| 0.113 | 0.262 | 0.335 | Thyroid hormone beta antagonist | 0.335 0.074 CID_68498 | CID_68498 | |
| 0.026 | 0.176 | 0.068 | Potassium channel (Inward rectifier) activator | 0.068 0.013 CID_68498 0.058 0.022 CID_93911 | CID_68498 | |
| 0.008 | 0.159 | 0.042 | 5-Alpha-reductase inhibitor | 0.042 0.022 CID_68498 | CID_68498 | |
| 0.014 | 0.166 | 0.076 | Prostaglandin EP2 antagonist | 0.076 0.029 CID_68498 | CID_68498 | |
| 0.016 | 0.169 | 0.074 | Carbonic anhydrase XIV inhibitor | 0.074 0.019 CID_93911 | CID_93911 | |
| 0.032 | 0.185 | 0.145 | Calcium antagonist | 0.145 0.024 CID_68498 | CID_68498 | |
| 0.018 | 0.172 | 0.053 | Histone deacetylase 9 inhibitor | 0.053 0.014 CID_68498 | CID_68498 | |
| 0.013 | 0.168 | 0.065 | Histone deacetylase 7 inhibitor | 0.065 0.014 CID_68498 | CID_68498 | |
| 0.018 | 0.173 | 0.035 | Somatostatin 4 agonist | 0.035 0.029 CID_93911 | CID_93911 | |
| 0.116 | 0.271 | 0.236 | 12-Lipoxygenase inhibitor | 0.236 0.117 CID_68498 0.186 0.167 CID_93911 | CID_68498 | |
| 0.079 | 0.234 | 0.154 | Heat shock protein 90 alpha antagonist | 0.154 0.082 CID_93911 | CID_93911 | |
| 0.033 | 0.189 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.09 0.02 CID_68498 | CID_68498 | |
| 0.027 | 0.186 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.108 0.025 CID_93911 | CID_93911 | |
| 0.071 | 0.232 | 0.263 | Phospholipase A2 inhibitor | 0.263 0.02 CID_68498 | CID_68498 | |
| 0.011 | 0.172 | 0.038 | Acid ceramidase inhibitor | 0.038 0.004 CID_68498 | CID_68498 | |
| 0.06 | 0.222 | 0.177 | Photosensitizer | 0.177 0.019 CID_68498 | CID_68498 | |
| 0.009 | 0.175 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.019 CID_68498 | CID_68498 | |
| 0.003 | 0.169 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 CID_68498 | CID_68498 | |
| 0.04 | 0.206 | 0.084 | Glutamate (mGluR6) antagonist | 0.084 0.02 CID_68498 0.075 0.031 CID_93911 | CID_68498 | |
| 0.011 | 0.178 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 CID_93911 | CID_93911 | |
| 0.016 | 0.184 | 0.053 | Retinoid X alpha receptor antagonist | 0.053 0.005 CID_68498 | CID_68498 | |
| 0.011 | 0.18 | 0.058 | Glutamate (mGluR group II) antagonist | 0.058 0.012 CID_68498 | CID_68498 | |
| 0.019 | 0.194 | 0.061 | Carbamoyl phosphate synthetase inhibitor | 0.06 0.043 CID_68498 0.061 0.042 CID_93911 | CID_93911 | |
| 0.058 | 0.235 | 0.286 | Aldehyde dehydrogenase inhibitor | 0.286 0.013 CID_68498 | CID_68498 | |
| 0.034 | 0.211 | 0.095 | Myeloperoxidase inhibitor | 0.095 0.041 CID_68498 | CID_68498 | |
| 0.036 | 0.214 | 0.138 | Pim-3 kinase inhibitor | 0.138 0.022 CID_93911 | CID_93911 | |
| 0.006 | 0.184 | 0.043 | Glutamate (mGluR2) antagonist | 0.043 0.01 CID_68498 | CID_68498 | |
| 0.001 | 0.179 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_93911 | CID_93911 | |
| 0.019 | 0.197 | 0.065 | Potassium channel Kv1.1 blocker | 0.065 0.007 CID_68498 | CID_68498 | |
| 0.008 | 0.186 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.013 CID_68498 | CID_68498 | |
| 0.043 | 0.222 | 0.102 | Glutathione S-transferase inhibitor | 0.102 0.035 CID_68498 | CID_68498 | |
| 0.018 | 0.198 | 0.132 | Prostaglandin-E synthase inhibitor | 0.132 0.016 CID_68498 | CID_68498 | |
| 0.021 | 0.201 | 0.045 | Kainate receptor agonist | 0.045 0.02 CID_68498 0.044 0.022 CID_93911 | CID_68498 | |
| 0.017 | 0.198 | 0.06 | Retinoid X receptor antagonist | 0.06 0.006 CID_68498 | CID_68498 | |
| 0.039 | 0.224 | 0.11 | Prolactin inhibitor | 0.096 0.06 CID_68498 0.11 0.046 CID_93911 | CID_93911 | |
| 0.049 | 0.234 | 0.119 | Beta amyloid protein antagonist | 0.119 0.069 CID_93911 | CID_93911 | |
| 0.079 | 0.264 | 0.209 | Melanin inhibitor | 0.209 0.038 CID_68498 | CID_68498 | |
| 0.047 | 0.233 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.082 CID_93911 | CID_93911 | |
| 0.022 | 0.209 | 0.082 | Aldosterone antagonist | 0.082 0.01 CID_68498 | CID_68498 | |
| 0.017 | 0.205 | 0.056 | 5 Hydroxytryptamine 2B agonist | 0.04 0.024 CID_68498 0.056 0.01 CID_93911 | CID_93911 | |
| 0.016 | 0.205 | 0.056 | Protein kinase (CK2) beta inhibitor | 0.056 0.005 CID_93911 | CID_93911 | |
| 0.084 | 0.273 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | 0.169 0.075 CID_68498 0.172 0.072 CID_93911 | CID_93911 | |
| 0.076 | 0.265 | 0.123 | DNA repair enzyme inhibitor | 0.123 0.066 CID_68498 | CID_68498 | |
| 0.004 | 0.193 | 0.022 | Nicotinic acid receptor 1 antagonist | 0.022 0.007 CID_68498 | CID_68498 | |
| 0.049 | 0.24 | 0.082 | Transcription factor NF kappa B stimulant | 0.082 0.066 CID_68498 | CID_68498 | |
| 0.033 | 0.225 | 0.128 | Alcohol dehydrogenase inhibitor | 0.128 0.03 CID_68498 | CID_68498 | |
| 0.006 | 0.198 | 0.061 | Glutamate (mGluR1a) agonist | 0.061 0.004 CID_68498 | CID_68498 | |
| 0.069 | 0.262 | 0.161 | Hexokinase inhibitor | 0.161 0.067 CID_93911 | CID_93911 | |
| 0.015 | 0.208 | 0.047 | Glutamate (mGluR3) agonist | 0.047 0.005 CID_68498 | CID_68498 | |
| 0.029 | 0.223 | 0.086 | Pregnane X receptor antagonist | 0.086 0.005 CID_68498 | CID_68498 | |
| 0.087 | 0.282 | 0.331 | Succinate dehydrogenase inhibitor | 0.331 0.007 CID_68498 | CID_68498 | |
| 0.024 | 0.219 | 0.064 | Topoisomerase II beta inhibitor | 0.064 0.019 CID_93911 | CID_93911 | |
| 0.039 | 0.235 | 0.077 | Transcription factor RelA inhibitor | 0.077 0.021 CID_68498 | CID_68498 | |
| 0.175 | 0.372 | 0.376 | Antiinflammatory | 0.376 0.155 CID_68498 | CID_68498 | |
| 0.09 | 0.287 | 0.158 | ATPase inhibitor | 0.158 0.089 CID_68498 0.137 0.127 CID_93911 | CID_68498 | |
| 0.028 | 0.226 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.052 CID_93911 | CID_93911 | |
| 0.124 | 0.323 | 0.245 | Sodium/bile acid cotransporter inhibitor | 0.245 0.133 CID_68498 | CID_68498 | |
| 0.054 | 0.253 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.056 CID_68498 | CID_68498 | |
| 0.007 | 0.206 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.038 0.006 CID_68498 0.025 0.022 CID_93911 | CID_68498 | |
| 0.039 | 0.239 | 0.338 | Ferrochelatase inhibitor | 0.338 0.005 CID_68498 0.116 0.056 CID_93911 | CID_68498 | |
| 0.006 | 0.209 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | 0.035 0.021 CID_68498 | CID_68498 | |
| 0.039 | 0.243 | 0.199 | Cystathionine beta-synthase inhibitor | 0.199 0.025 CID_68498 | CID_68498 | |
| 0.004 | 0.208 | 0.024 | Adenosine kinase inhibitor | 0.024 0.013 CID_93911 | CID_93911 | |
| 0.008 | 0.213 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 CID_68498 | CID_68498 | |
| 0.01 | 0.216 | 0.057 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 CID_93911 | CID_93911 | |
| 0.021 | 0.227 | 0.121 | Histidine decarboxylase inhibitor | 0.121 0.025 CID_93911 | CID_93911 | |
| 0.042 | 0.249 | 0.145 | Triose-phosphate isomerase inhibitor | 0.145 0.022 CID_68498 | CID_68498 | |
| 0.017 | 0.228 | 0.069 | Pim-2 kinase inhibitor | 0.069 0.025 CID_93911 | CID_93911 | |
| 0.033 | 0.246 | 0.117 | Potassium channel activator | 0.117 0.034 CID_68498 | CID_68498 | |
| 0.113 | 0.326 | 0.333 | Vasodilator, coronary | 0.333 0.064 CID_68498 | CID_68498 | |
| 0.032 | 0.246 | 0.108 | Falcipain 3 inhibitor | 0.108 0.063 CID_68498 | CID_68498 | |
| 0.015 | 0.23 | 0.043 | Mineralocorticoid receptor antagonist | 0.043 0.041 CID_68498 | CID_68498 | |
| 0.023 | 0.238 | 0.088 | Fatty acid synthase inhibitor | 0.088 0.015 CID_68498 | CID_68498 | |
| 0.02 | 0.237 | 0.097 | Lipase inhibitor | 0.097 0.029 CID_68498 | CID_68498 | |
| 0.016 | 0.233 | 0.149 | TRPA1 antagonist | 0.149 0.009 CID_68498 | CID_68498 | |
| 0.053 | 0.27 | 0.082 | 3C-Like protease (SARS coronavirus) inhibitor | 0.082 0.062 CID_93911 | CID_93911 | |
| 0.022 | 0.242 | 0.051 | Heparanase inhibitor | 0.051 0.042 CID_68498 | CID_68498 | |
| 0.108 | 0.328 | 0.233 | Antithrombotic | 0.222 0.151 CID_68498 0.233 0.141 CID_93911 | CID_93911 | |
| 0.125 | 0.345 | 0.278 | Antibacterial | 0.278 0.152 CID_68498 0.239 0.187 CID_93911 | CID_68498 | |
| 0.037 | 0.261 | 0.394 | GABA C receptor agonist | 0.141 0.038 CID_68498 0.394 0.005 CID_93911 | CID_93911 | |
| 0.1 | 0.325 | 0.65 | 5 Hydroxytryptamine release stimulant | 0.65 0.01 CID_68498 0.37 0.052 CID_93911 | CID_68498 | |
| 0.049 | 0.275 | 0.174 | Cathepsin H inhibitor | 0.174 0.032 CID_68498 0.119 0.077 CID_93911 | CID_68498 | |
| 0.028 | 0.254 | 0.102 | Inducible nitric-oxide synthase inhibitor | 0.102 0.035 CID_68498 0.094 0.042 CID_93911 | CID_68498 | |
| 0.034 | 0.261 | 0.086 | Glycine receptor agonist | 0.085 0.032 CID_68498 0.086 0.032 CID_93911 | CID_93911 | |
| 0.031 | 0.259 | 0.116 | Expectorant | 0.116 0.054 CID_93911 | CID_93911 | |
| 0.02 | 0.248 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.019 CID_68498 | CID_68498 | |
| 0.05 | 0.28 | 0.175 | Toll-Like receptor 2 antagonist | 0.175 0.036 CID_68498 0.111 0.089 CID_93911 | CID_68498 | |
| 0.018 | 0.248 | 0.063 | Leukotriene B4 antagonist | 0.063 0.024 CID_68498 | CID_68498 | |
| 0.025 | 0.256 | 0.057 | Dihydroorotate oxidase inhibitor | 0.057 0.035 CID_68498 0.055 0.038 CID_93911 | CID_68498 | |
| 0.014 | 0.247 | 0.049 | GABA receptor antagonist | 0.049 0.047 CID_68498 | CID_68498 | |
| 0.017 | 0.25 | 0.059 | Beta 2 adrenoreceptor antagonist | 0.059 0.025 CID_93911 | CID_93911 | |
| 0.052 | 0.286 | 0.127 | Acetylcholine release stimulant | 0.127 0.037 CID_68498 | CID_68498 | |
| 0.017 | 0.252 | 0.066 | HIV-1 reverse transcriptase inhibitor | 0.066 0.053 CID_68498 | CID_68498 | |
| 0.004 | 0.241 | 0.044 | Purinergic P2T antagonist | 0.044 0.01 CID_68498 | CID_68498 | |
| 0.036 | 0.272 | 0.144 | Potassium channel (Voltage-sensitive) activator | 0.144 0.015 CID_68498 | CID_68498 | |
| 0.017 | 0.256 | 0.067 | Aconitate hydratase inhibitor | 0.067 0.02 CID_68498 | CID_68498 | |
| 0.006 | 0.246 | 0.034 | Potassium channel subfamily K member 3 blocker | 0.034 0.017 CID_68498 | CID_68498 | |
| 0.098 | 0.339 | 0.289 | Immunosuppressant | 0.289 0.122 CID_68498 | CID_68498 | |
| 0.01 | 0.251 | 0.037 | Melanocortin 1 antagonist | 0.037 0.027 CID_68498 | CID_68498 | |
| 0.004 | 0.246 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 CID_68498 | CID_68498 | |
| 0.02 | 0.261 | 0.065 | Histone deacetylase inhibitor | 0.065 0.046 CID_68498 | CID_68498 | |
| 0.052 | 0.293 | 0.147 | TRPA1 agonist | 0.147 0.033 CID_68498 | CID_68498 | |
| 0.024 | 0.265 | 0.109 | Potassium channel intermediate-conductance Ca-activated blocker | 0.109 0.007 CID_68498 | CID_68498 | |
| 0.036 | 0.277 | 0.126 | Anabolic | 0.126 0.034 CID_68498 | CID_68498 | |
| 0.012 | 0.254 | 0.069 | Sphingosine 1-phosphate receptor agonist | 0.069 0.012 CID_68498 | CID_68498 | |
| 0.025 | 0.268 | 0.067 | Purinergic P2X1 antagonist | 0.067 0.035 CID_68498 | CID_68498 | |
| 0.019 | 0.263 | 0.062 | Sphingosine kinase 2 inhibitor | 0.062 0.029 CID_68498 | CID_68498 | |
| 0.069 | 0.315 | 0.181 | Adenylate cyclase stimulant | 0.133 0.094 CID_68498 0.181 0.025 CID_93911 | CID_93911 | |
| 0.026 | 0.272 | 0.094 | Glutamate (mGluR7) antagonist | 0.094 0.014 CID_68498 | CID_68498 | |
| 0.014 | 0.261 | 0.084 | Phosphofructokinase-1 inhibitor | 0.084 0.039 CID_68498 0.072 0.046 CID_93911 | CID_68498 | |
| 0.061 | 0.31 | 0.307 | Interleukin agonist | 0.307 0.045 CID_68498 | CID_68498 | |
| 0.013 | 0.264 | 0.134 | Argininosuccinate synthase inhibitor | 0.134 0.013 CID_68498 | CID_68498 | |
| 0.005 | 0.259 | 0.038 | Kainate receptor antagonist | 0.038 0.031 CID_93911 | CID_93911 | |
| 0.005 | 0.261 | 0.041 | Purinergic P2Y12 antagonist | 0.041 0.008 CID_68498 | CID_68498 | |
| 0.038 | 0.294 | 0.106 | Bile acid receptor antagonist | 0.106 0.037 CID_68498 | CID_68498 | |
| 0.005 | 0.262 | 0.053 | Free fatty acid receptor 1 antagonist | 0.053 0.008 CID_68498 | CID_68498 | |
| 0.007 | 0.265 | 0.05 | Peroxisome proliferator-activated receptor alpha agonist | 0.05 0.032 CID_68498 | CID_68498 | |
| 0.102 | 0.362 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.096 CID_93911 | CID_93911 | |
| 0.022 | 0.282 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.045 CID_93911 | CID_93911 | |
| 0.05 | 0.311 | 0.184 | Protein kinase stimulant | 0.184 0.048 CID_68498 0.122 0.09 CID_93911 | CID_68498 | |
| 0.057 | 0.32 | 0.221 | MAP kinase kinase 2 inhibitor | 0.221 0.069 CID_93911 | CID_93911 | |
| 0.039 | 0.304 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 CID_93911 | CID_93911 | |
| 0.016 | 0.285 | 0.062 | Androgen agonist | 0.062 0.039 CID_93911 | CID_93911 | |
| 0.036 | 0.306 | 0.084 | MAP kinase kinase 1 inhibitor | 0.084 0.08 CID_93911 | CID_93911 | |
| 0.02 | 0.289 | 0.067 | Epoxide hydrolase inhibitor | 0.067 0.058 CID_68498 | CID_68498 | |
| 0.005 | 0.276 | 0.056 | Sphingosine 1-phosphate receptor 1 agonist | 0.056 0.015 CID_68498 | CID_68498 | |
| 0.121 | 0.393 | 0.208 | 5 Hydroxytryptamine 3E antagonist | 0.208 0.05 CID_68498 0.171 0.132 CID_93911 | CID_68498 | |
| 0.051 | 0.325 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.113 CID_93911 | CID_93911 | |
| 0.053 | 0.329 | 0.145 | Aurora-C kinase inhibitor | 0.145 0.057 CID_93911 | CID_93911 | |
| 0.087 | 0.367 | 0.313 | Gastrin inhibitor | 0.313 0.025 CID_68498 | CID_68498 | |
| 0.045 | 0.326 | 0.155 | NADPH oxidase inhibitor | 0.155 0.051 CID_68498 | CID_68498 | |
| 0.029 | 0.313 | 0.087 | Exportin-1 inhibitor | 0.087 0.017 CID_68498 | CID_68498 | |
| 0.047 | 0.333 | 0.143 | Cell wall synthesis inhibitor | 0.143 0.072 CID_68498 0.119 0.101 CID_93911 | CID_68498 | |
| 0.015 | 0.302 | 0.029 | Thiazolidinedione | 0.029 0.022 CID_68498 | CID_68498 | |
| 0.005 | 0.292 | 0.054 | Geranyltranstransferase inhibitor | 0.054 0.019 CID_68498 | CID_68498 | |
| 0.05 | 0.338 | 0.131 | Glutamate release inhibitor | 0.131 0.016 CID_68498 | CID_68498 | |
| 0.02 | 0.309 | 0.054 | Alpha 1L adrenoreceptor agonist | 0.054 0.013 CID_93911 | CID_93911 | |
| 0.005 | 0.294 | 0.03 | Glucagon receptor antagonist | 0.03 0.02 CID_68498 | CID_68498 | |
| 0.037 | 0.327 | 0.212 | Alpha-N-acetylglucosaminidase inhibitor | 0.212 0.031 CID_68498 0.202 0.033 CID_93911 | CID_68498 | |
| 0.011 | 0.302 | 0.043 | Acetyl-CoA transferase 1 inhibitor | 0.043 0.026 CID_68498 | CID_68498 | |
| 0.139 | 0.431 | 0.549 | 5 Hydroxytryptamine release inhibitor | 0.549 0.02 CID_68498 | CID_68498 | |
| 0.006 | 0.299 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.017 CID_68498 | CID_68498 | |
| 0.017 | 0.31 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.021 CID_68498 | CID_68498 | |
| 0.013 | 0.308 | 0.087 | Purinergic P2 antagonist | 0.087 0.028 CID_68498 | CID_68498 | |
| 0.004 | 0.306 | 0.047 | Nicotinic alpha3beta4 receptor agonist | 0.047 0.007 CID_93911 | CID_93911 | |
| 0.029 | 0.331 | 0.096 | Mucolytic | 0.096 0.084 CID_93911 | CID_93911 | |
| 0.005 | 0.307 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.032 CID_68498 | CID_68498 | |
| 0.014 | 0.316 | 0.21 | Catalase inhibitor | 0.21 0.014 CID_68498 | CID_68498 | |
| 0.064 | 0.367 | 0.158 | Vanilloid 1 agonist | 0.158 0.031 CID_68498 | CID_68498 | |
| 0.073 | 0.376 | 0.223 | Alpha-glucosidase inhibitor | 0.223 0.204 CID_68498 | CID_68498 | |
| 0.025 | 0.33 | 0.095 | Caspase 7 inhibitor | 0.095 0.035 CID_68498 | CID_68498 | |
| 0.027 | 0.332 | 0.089 | GABA A receptor agonist | 0.089 0.049 CID_68498 | CID_68498 | |
| 0.027 | 0.334 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.045 CID_68498 | CID_68498 | |
| 0.026 | 0.334 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.055 CID_68498 | CID_68498 | |
| 0.083 | 0.392 | 0.334 | 15-Lipoxygenase inhibitor | 0.334 0.108 CID_68498 | CID_68498 | |
| 0.031 | 0.344 | 0.129 | Alkaline phosphatase inhibitor | 0.129 0.076 CID_68498 | CID_68498 | |
| 0.076 | 0.39 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.119 CID_68498 | CID_68498 | |
| 0.004 | 0.319 | 0.038 | TRPM8 blocker | 0.038 0.027 CID_68498 | CID_68498 | |
| 0.006 | 0.322 | 0.039 | Guanylate cyclase inhibitor | 0.039 0.035 CID_68498 | CID_68498 | |
| 0.086 | 0.404 | 0.233 | Transcription factor inhibitor | 0.233 0.199 CID_68498 | CID_68498 | |
| 0.011 | 0.328 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.034 CID_68498 | CID_68498 | |
| 0.014 | 0.332 | 0.06 | Sphingosine kinase inhibitor | 0.06 0.039 CID_68498 | CID_68498 | |
| 0.016 | 0.335 | 0.074 | Carbonic anhydrase stimulant | 0.074 0.029 CID_68498 | CID_68498 | |
| 0.018 | 0.339 | 0.079 | Sphingosine 1-phosphate receptor 1 antagonist | 0.079 0.014 CID_68498 | CID_68498 | |
| 0.012 | 0.335 | 0.086 | CDC7 inhibitor | 0.086 0.032 CID_93911 | CID_93911 | |
| 0.014 | 0.338 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.02 CID_68498 | CID_68498 | |
| 0.006 | 0.331 | 0.03 | Cholesterol ester transfer protein antagonist | 0.03 0.024 CID_68498 | CID_68498 | |
| 0.004 | 0.329 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.041 0.007 CID_93911 | CID_93911 | |
| 0.034 | 0.36 | 0.101 | Microtubule formation inhibitor | 0.101 0.089 CID_68498 0.101 0.09 CID_93911 | CID_93911 | |
| 0.08 | 0.406 | 0.174 | Neurotensin receptor agonist | 0.174 0.057 CID_68498 | CID_68498 | |
| 0.126 | 0.456 | 0.188 | MAP kinase kinase 3 inhibitor | 0.188 0.16 CID_93911 | CID_93911 | |
| 0.026 | 0.357 | 0.251 | GABA C receptor antagonist | 0.15 0.03 CID_68498 0.251 0.006 CID_93911 | CID_93911 | |
| 0.016 | 0.347 | 0.08 | CYP2A6 inhibitor | 0.078 0.05 CID_68498 0.08 0.048 CID_93911 | CID_93911 | |
| 0.008 | 0.341 | 0.031 | Glutamate (mGluR1) agonist | 0.031 0.009 CID_68498 | CID_68498 | |
| 0.012 | 0.345 | 0.031 | Hedgehog signaling activator | 0.031 0.011 CID_68498 | CID_68498 | |
| 0.021 | 0.355 | 0.082 | Potassium channel (Ca-activated) activator | 0.082 0.073 CID_68498 | CID_68498 | |
| 0.052 | 0.386 | 0.275 | Calpain inhibitor | 0.275 0.045 CID_68498 | CID_68498 | |
| 0.006 | 0.341 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 CID_68498 | CID_68498 | |
| 0.03 | 0.37 | 0.133 | GABA receptor agonist | 0.133 0.046 CID_68498 | CID_68498 | |
| 0.031 | 0.372 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.072 CID_68498 | CID_68498 | |
| 0.017 | 0.359 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.053 CID_68498 | CID_68498 | |
| 0.002 | 0.344 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 CID_68498 | CID_68498 | |
| 0.013 | 0.357 | 0.082 | Porphobilinogen synthase inhibitor | 0.082 0.046 CID_68498 | CID_68498 | |
| 0.036 | 0.381 | 0.066 | Calcium channel P-type blocker | 0.066 0.036 CID_68498 | CID_68498 | |
| 0.04 | 0.387 | 0.113 | Cyclooxygenase 3 inhibitor | 0.113 0.085 CID_68498 | CID_68498 | |
| 0.061 | 0.408 | 0.201 | Phospholipase C inhibitor | 0.201 0.043 CID_68498 0.144 0.118 CID_93911 | CID_68498 | |
| 0.003 | 0.35 | 0.02 | Nicotinic alpha4 receptor agonist | 0.02 0.007 CID_93911 | CID_93911 | |
| 0.007 | 0.355 | 0.047 | Glutamate (mGluR5) agonist | 0.047 0.03 CID_68498 | CID_68498 | |
| 0.006 | 0.355 | 0.045 | Alpha 1d adrenoreceptor agonist | 0.045 0.02 CID_68498 | CID_68498 | |
| 0.005 | 0.358 | 0.068 | Ornithine carbamoyltransferase inhibitor | 0.068 0.027 CID_68498 | CID_68498 | |
| 0.017 | 0.369 | 0.062 | Cyclin B3 inhibitor | 0.062 0.053 CID_93911 | CID_93911 | |
| 0.003 | 0.357 | 0.04 | Uridine phosphorylase inhibitor | 0.04 0.012 CID_68498 | CID_68498 | |
| 0.004 | 0.36 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.018 CID_93911 | CID_93911 | |
| 0.007 | 0.365 | 0.052 | Leukocyte elastase inhibitor | 0.052 0.022 CID_68498 | CID_68498 | |
| 0.018 | 0.377 | 0.071 | Cathepsin G inhibitor | 0.071 0.052 CID_68498 | CID_68498 | |
| 0.005 | 0.366 | 0.032 | Liver X receptor beta antagonist | 0.032 0.017 CID_68498 | CID_68498 | |
| 0.012 | 0.379 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.052 CID_68498 | CID_68498 | |
| 0.073 | 0.443 | 0.173 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.114 CID_68498 0.173 0.103 CID_93911 | CID_93911 | |
| 0.029 | 0.4 | 0.1 | Proteasome inhibitor | 0.1 0.087 CID_68498 | CID_68498 | |
| 0.066 | 0.437 | 0.293 | Hypoglycemic | 0.293 0.055 CID_68498 | CID_68498 | |
| 0.027 | 0.402 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_68498 | CID_68498 | |
| 0.008 | 0.386 | 0.073 | Alcohol oxidase inhibitor | 0.073 0.027 CID_68498 | CID_68498 | |
| 0.005 | 0.382 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 CID_68498 | CID_68498 | |
| 0.007 | 0.386 | 0.038 | Oxytocin agonist | 0.038 0.034 CID_68498 | CID_68498 | |
| 0.008 | 0.389 | 0.081 | Acyl-CoA dehydrogenase inhibitor | 0.081 0.022 CID_68498 | CID_68498 | |
| 0.004 | 0.386 | 0.059 | Glutamate (mGluR1) antagonist | 0.059 0.04 CID_68498 | CID_68498 | |
| 0.006 | 0.388 | 0.05 | Glutamate (mGluR group I) agonist | 0.05 0.031 CID_68498 | CID_68498 | |
| 0.046 | 0.43 | 0.167 | Tumour necrosis factor alpha release inhibitor | 0.167 0.137 CID_68498 | CID_68498 | |
| 0.014 | 0.399 | 0.095 | Pim-1 kinase inhibitor | 0.095 0.063 CID_93911 | CID_93911 | |
| 0.039 | 0.427 | 0.189 | Prostaglandin dehydrogenase inhibitor | 0.189 0.165 CID_68498 | CID_68498 | |
| 0.076 | 0.464 | 0.48 | Histamine release inhibitor | 0.48 0.036 CID_68498 | CID_68498 | |
| 0.009 | 0.399 | 0.06 | Benzodiazepine antagonist | 0.06 0.013 CID_68498 | CID_68498 | |
| 0.005 | 0.395 | 0.088 | 5 Hydroxytryptamine 2C agonist | 0.088 0.009 CID_93911 | CID_93911 | |
| 0.009 | 0.4 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 CID_68498 | CID_68498 | |
| 0.04 | 0.437 | 0.257 | Aldehyde oxidase inhibitor | 0.257 0.079 CID_68498 | CID_68498 | |
| 0.039 | 0.436 | 0.16 | Sphingosine 1-phosphate receptor 4 antagonist | 0.16 0.025 CID_68498 | CID_68498 | |
| 0.084 | 0.481 | 0.44 | GABA C receptor rho-3 antagonist | 0.44 0.045 CID_68498 0.319 0.104 CID_93911 | CID_68498 | |
| 0.031 | 0.43 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | 0.116 0.018 CID_68498 | CID_68498 | |
| 0.008 | 0.408 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 CID_68498 | CID_68498 | |
| 0.009 | 0.41 | 0.058 | Glutamate (mGluR1a) antagonist | 0.058 0.016 CID_68498 | CID_68498 | |
| 0.021 | 0.423 | 0.195 | Gastric antisecretory | 0.195 0.013 CID_68498 | CID_68498 | |
| 0.029 | 0.44 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.069 CID_68498 0.08 0.076 CID_93911 | CID_68498 | |
| 0.031 | 0.444 | 0.141 | Electron transport complex I inhibitor | 0.141 0.026 CID_68498 | CID_68498 | |
| 0.02 | 0.433 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.051 CID_68498 | CID_68498 | |
| 0.039 | 0.453 | 0.128 | Adenylate kinase inhibitor | 0.128 0.038 CID_68498 | CID_68498 | |
| 0.01 | 0.428 | 0.113 | Sphingosine 1-phosphate receptor 4 agonist | 0.113 0.019 CID_68498 | CID_68498 | |
| 0.065 | 0.486 | 0.182 | Death-associated protein kinase 2 inhibitor | 0.182 0.052 CID_68498 | CID_68498 | |
| 0.02 | 0.449 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.051 CID_68498 | CID_68498 | |
| 0.038 | 0.468 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.041 CID_68498 | CID_68498 | |
| 0.006 | 0.449 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 CID_68498 | CID_68498 | |
| 0.037 | 0.483 | 0.127 | Thiol protease inhibitor | 0.127 0.102 CID_68498 | CID_68498 | |
| 0.005 | 0.451 | 0.037 | Delayed rectifier potassium channel activator | 0.037 0.025 CID_68498 | CID_68498 | |
| 0.005 | 0.451 | 0.037 | Potassium channel KCNQ activator | 0.037 0.025 CID_68498 | CID_68498 | |
| 0.001 | 0.452 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 CID_68498 | CID_68498 | |
| 0.013 | 0.465 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.054 CID_93911 | CID_93911 | |
| 0.018 | 0.473 | 0.095 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.052 CID_93911 | CID_93911 | |
| 0.01 | 0.47 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.069 CID_93911 | CID_93911 | |
| 0.087 | 0.55 | 0.249 | Interleukin 2 agonist | 0.249 0.119 CID_68498 | CID_68498 | |
| 0.011 | 0.481 | 0.077 | Secretase beta inhibitor | 0.077 0.039 CID_68498 | CID_68498 | |
| 0.028 | 0.499 | 0.102 | DNA polymerase I inhibitor | 0.102 0.084 CID_68498 | CID_68498 | |
| 0.04 | 0.519 | 0.315 | Calpain 2 inhibitor | 0.315 0.105 CID_68498 | CID_68498 | |
| 0.015 | 0.515 | 0.105 | Ornithine decarboxylase inhibitor | 0.105 0.039 CID_68498 | CID_68498 | |
| 0.018 | 0.525 | 0.079 | Keratolytic | 0.079 0.049 CID_68498 | CID_68498 | |
| 0.019 | 0.529 | 0.157 | GABA C receptor rho-1 antagonist | 0.109 0.05 CID_68498 0.157 0.019 CID_93911 | CID_93911 | |
| 0.029 | 0.542 | 0.134 | Peroxidase inhibitor | 0.134 0.087 CID_68498 0.118 0.102 CID_93911 | CID_68498 | |
| 0.019 | 0.536 | 0.172 | I kappa B kinase epsilon inhibitor | 0.172 0.097 CID_93911 | CID_93911 | |
| 0.016 | 0.533 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.069 CID_68498 | CID_68498 | |
| 0.027 | 0.546 | 0.088 | Carbonic anhydrase XV inhibitor | 0.088 0.087 CID_68498 | CID_68498 | |
| 0.007 | 0.538 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.022 CID_68498 | CID_68498 | |
| 0.011 | 0.548 | 0.087 | MAP-kinase-activated kinase 2 inhibitor | 0.087 0.037 CID_93911 | CID_93911 | |
| 0.031 | 0.573 | 0.156 | GABA C receptor rho-2 antagonist | 0.153 0.07 CID_68498 0.156 0.066 CID_93911 | CID_93911 | |
| 0.008 | 0.554 | 0.029 | Glucosylceramidase stimulant | 0.029 0.013 CID_68498 | CID_68498 | |
| 0.037 | 0.586 | 0.148 | CF transmembrane conductance regulator agonist | 0.148 0.08 CID_68498 | CID_68498 | |
| 0.019 | 0.576 | 0.114 | Electrolyte absorption antagonist | 0.114 0.041 CID_68498 | CID_68498 | |
| 0.014 | 0.576 | 0.096 | MAP-kinase-activated kinase inhibitor | 0.096 0.043 CID_93911 | CID_93911 | |
| 0.006 | 0.573 | 0.059 | Dihydroorotase inhibitor | 0.059 0.017 CID_68498 | CID_68498 | |
| 0.007 | 0.579 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.019 CID_68498 | CID_68498 | |
| 0.019 | 0.594 | 0.11 | Antibacterial (Helicobacter pylori) | 0.11 0.098 CID_68498 | CID_68498 | |
| 0.008 | 0.596 | 0.08 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.08 0.036 CID_68498 | CID_68498 | |
| 0.043 | 0.643 | 0.191 | Insulysin inhibitor | 0.191 0.171 CID_68498 | CID_68498 | |
| 0.088 | 0.692 | 0.266 | Calcium channel L-type activator | 0.266 0.188 CID_93911 | CID_93911 | |
| 0.013 | 0.656 | 0.064 | Corticotropin releasing factor 2 receptor antagonist | 0.064 0.038 CID_68498 | CID_68498 | |
| 0.017 | 0.675 | 0.123 | Hemostatic | 0.123 0.108 CID_68498 | CID_68498 | |
| 0.018 | 0.689 | 0.126 | Cytokine production inhibitor | 0.126 0.084 CID_68498 | CID_68498 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |